ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension-Reference-Cited by-同舟云学术

ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension

Published:2011-06-20 Issue:2 Volume:30 Page:93-99
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:

Author:

Badesch David B.,Feldman Jeremy,Keogh Anne,Mathier Michael A.,Oudiz Ronald J.,Shapiro Shelley,Farber Harrison W.,McGoon Michael,Frost Adaani,Allard Martine,Despain Darrin,Dufton Christopher,Rubin Lewis J.,

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2011.00279.x/fullpdf

Reference21 articles.

1. Clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2004

2. Primary pulmonary hypertension;Rubin;Chest,1993

3. Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines;Badesch;Chest,2007

4. Cellular and molecular basis of pulmonary arterial hypertension;Morrell;J Am Coll Cardiol,2009

5. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension;Peacock;Proc Am Thorac Soc,2006

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review;Thrombosis Research;2024-03

2. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know – but is afraid to ask!;La Revue de Médecine Interne;2024-01

3. Mixed Connective Tissue Disease Complicated with Pulmonary Hypertension in Which Respiratory Failure Was Exacerbated by Pregnancy and Delivery: A Case Report;Respiratory Endoscopy;2023-11-29

4. Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance;Pharmacoepidemiology and Drug Safety;2023-07-27

5. Diagnosis and management of pulmonary hypertension related to chronic respiratory disease;Breathe;2022-12